MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    AI based longitudinal changes in substantia nigra contrast and volume on neuromelanin MRI and its relation to clinical markers in a multi-site Parkinson’s disease study.

    M. Ingalhalikar, H. Pham, T. G, L. Bracoud, MH. Hutchison, K. Evans, T. Dam, KN. Nguyen, CC. Conklin, JS. Suhy, DS. Scott (San Mateo, USA)

    Objective: To apply an AI model in a multi-site longitudinal study to segment substantia nigra pars compacta (SNpc), perform longitudinal analysis, and quantify its association…
  • 2024 International Congress

    Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

    MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)

    Objective: To evaluate the progression of posterior putamen dopaminergic denervation in relation to motor progression in the less affected and more affected side of the…
  • 2024 International Congress

    Regional Brain Volume Differences Across PD Clinical Subtypes

    A. Eid, S. Grossen, A. Tanenbaum, J. Hood, H. Hwang, T. Cash, C. Lessov-Schlaggar, P. Kotzbauer, J. Perlmutter, M. Campbell (SAINT LOUIS, USA)

    Objective: To investigate brain morphometric differences across Parkinson disease (PD) clinical subtypes. Background: We developed a PD subtype classification with three subtypes that includes motor…
  • 2024 International Congress

    Reduced parietal and sensorimotor cortex recruitment during complex gait in Parkinson’s disease patients with freezing of gait

    N. D'Cruz, M. Goris, C. Mccrum, A. Nieuwboer, M. Gilat (Leuven, Belgium)

    Objective: To investigate cortical brain activity changes during complex gait in Parkinson’s disease (PD) patients with and without freezing of gait (FOG) using functional near…
  • 2024 International Congress

    Characterization of a Novel alpha-synuclein PET radiotracer, [18F]C05-05, in a PPMI Sub-study

    D. Russell, C. Constantinescu, R. Gunn, J. Eberling, A. Lorenzo, M. Rowland, S. Roman, J. Seibyl, K. Marek, MJF. Imaging Consortium, THE. Ppmi Study (New Haven, USA)

    Objective: Characterization of the PET radiotracer, [18F]C05-05, in the PPMI Study Background: Validation of imaging biomarkers in Parkinson disease (PD) is a major objective of…
  • 2024 International Congress

    MRI Visible Perivascular Spaces are Associated with Disease Duration and Severity in Parkinson’s Disease

    D. Hemachandra, K. Younes, E. Peterson, J. Winer, Y. Cobbigo, H. Rosen, C. Young, T. Schulte, K. Poston, E. Müller-Oehring (Palo Alto, USA)

    Objective: Determine whether enlarged perivascular spaces (ePVS) in Parkinson's disease (PD) is associated with worsening motor symptoms and disease progression. Background: PVS are fluid-filled channels…
  • 2024 International Congress

    Characterizing levodopa-induced dyskinesias using multimodal neuroimaging, clinical and behavioral measures

    S. Shukla, S. Tinaz, N. Thirugnanasambandam (Mumbai, India)

    Objective: Our objective is to investigate potential differential modulation in motor and executive function networks among patients with LID, and to explore its correlation with…
  • 2024 International Congress

    Refining and Understanding Causal Relationships between Brain Imaging-Derived Phenotypes and Parkinson’s Disease: a Bidirectional Mendelian Randomization Study and Clinical Validation

    M. Niu, Y. Zhang (Shanghai, China)

    Objective: Utilizing bidirectional two-sample Mendelian randomization, we explored the causal associations between imaging-derived phenotypes (IDPs) and Parkinson's Disease (PD), along with its manifestations. Background: Observational…
  • 2024 International Congress

    Mapping Cholinergic Signaling in Parkinson Disease Using [18F]VAT

    J. O'Donnell, M. Campbell, S. Norris, B. Maiti, A. Soda, S. Moerlein, Z. Tu, J. Perlmutter (St. Louis, USA)

    Objective: To determine how cholinergic signaling changes within Parkinson Disease (PD) and how these differences relate to the progression of cognitive and behavioral symptoms. Background:…
  • 2024 International Congress

    Naturalistic walking in Parkinson’s disease: Prefrontal cortex activity measured with functional near-infrared spectroscopy (fNIRS)

    R. Kaplan, N. Mukadam, C. Aul, M. Rowe, N. Eklund, T. Nordahl, M. Yücel, T. Ellis, A. Cronin-Golomb (Boston, USA)

    Objective: In persons with Parkinson’s disease (PwPD), to observe brain activity in prefrontal cortex (PFC) using fNIRS during naturalistic walking that mimics everyday scenarios1, with…
  • « Previous Page
  • 1
  • …
  • 488
  • 489
  • 490
  • 491
  • 492
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley